Jason Haas

Affiliations

  • Director at Ligand Pharmaceuticals Inc (LGND), 2025-06-10
  • Chief Financial Officer at Syros Pharmaceuticals Inc. (SYRS), 2024-11-20
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
SYRS $1.68 45,344 $76,005.61 124,552 2024-09-12 Filing
SYRS $1.58 19,293 $30,446.28 79,208 2024-09-11 Filing
SYRS $1.55 35,363 $54,787.90 59,915 2024-09-10 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
SYRS $0.21 137,803 $28,979.97 0 2024-11-18 Filing